Store

Home | Store | At-Home Testing COVID-19 Trends and Future Potential

At-Home Testing COVID-19 Trends and Future Potential

Publication Date: April 15, 2021

SKU: 21-052

Tags: COVID-19, Diagnostic Instruments, Infectious Disease Testing Instruments, Point-of-Care (POC) Testing

Pages: 90

SKU: 21-052

Kalorama Information’s first edition report, At-Home Testing: COVID-19 Trends and Future Potential, offers an in-depth analysis of the burgeoning home testing industry amid the COVID-19 pandemic. This report examines developments from the onset of the pandemic in 2020 through March 31, 2021, highlighting key trends and future prospects in the market.

 

Key Highlights of the Report:

  • Market Definition: The report defines home or self-tests as those where individuals collect samples, perform tests, and interpret results independently or with online consultation services.
  • Geographic Focus: The primary market for COVID-19 self-tests as of Spring 2021 is the United States, and the report predominantly focuses on this region.
  • Technologies: Coverage includes non-instrumented point-of-care (POC) COVID-19 tests that utilize immunoassays and molecular technologies, with the potential to evolve into home-based tests.

 

Trends and Issues Covered:

  • Government Support for COVID-19 Home Tests: Analysis of how governmental policies and support mechanisms are shaping the home testing market.
  • COVID-19 Home Test Sample Types: Overview of various sample collection methods for home testing.
  • COVID-19 Home Test Modalities: Examination of different testing modalities used in home COVID-19 tests.
  • OTC and DTC Trends in COVID-19 Testing: Insights into over-the-counter (OTC) and direct-to-consumer (DTC) trends and their impact on the market.

 

Technological and Market Developments:

  • Current and Future COVID-19 Tests: Detailed discussion on the COVID-19 tests and technologies available now and those anticipated to emerge.
  • Market Dynamics: Exploration of the factors driving market growth and the challenges faced by the home testing industry.

 

Company Profiles:

The report profiles several key players active in the COVID-19 home testing market, providing insights into their strategies, products, and market positioning.

 

Table: Major Test Technologies Used in Rapid Diagnostic Tests for COVID-19 (%)

Technology Percent
PCR XX%
EIA XX%
LF EIA XX%
CRISPR XX%
Biosensor XX%
LAMP XX%

Source: Kalorama Information

For further details and to purchase directly, please contact us.

Table of Contents

Chapter 1:  Executive Summary

  • Background
  • Scope and Methodology
    • United States of America
    • Canada
    • Europe
    • United Kingdom
  • Definitions
  • Point of View
    • Table 1-1 Speculative Projection of Home Testing for Test Categories FY 2021 (COVID-19, UTIs, STDs, HIV, Cholesterol and Other Categories)

 

Chapter 2: Government Support for COVID-19 Home Tests

  • Background
  • S. EUA Tests and Home Test Services
  • Canada’s COVID-19 Test Initiative
    • Table 2-1 Number of Canada Authorized COVID-19 Testing Devices (Rapid Point-Of-Care, Antigen Testing Devices, Nucleic Acid Testing Devices [PCR], and Serological Testing Devices)

Resources

  • COVID-19 Test Initiatives in Europe and the UK
    • Table 2-2 Selected CE Marked Rapid, POC COVID-19 Tests (Abbott Laboratories, Cellex, Coris Bioconcept, Cue Health, HiberGene Diagnostics, Laipac Technology, LumiraDX, Mast Group, Mologic, MP Biomedicals, PerkinElmer, Roche Diagnostics, SD Biosensors, and Siemens Healthineers)

 

Chapter 3: COVID-19 Home Test Sample Types

  • Background
    • Table 3-1 Major Sample Types Used in Rapid Diagnostic Tests For COVID-19 (Nasopharyngeal Swab, Anterior Nasal Swab, Saliva, and Breath)
  • Sample Self Collection Kits
    • Table 3-2 Selected COVID-19 Authorized Sample Collection Kits (Amazon, BioReference Laboratories, GenMark/Roche Diagnostics, Gravity Diagnostics, Laboratory Corp. America [LabCorp], LetsGetChecked, Quest Diagnostics, RapidRona, Walgreens, Color, DxTerity Diagnostics, Fluidigm, hims & hers, OraSure Technologies, Phosphorus Diagnostics, Thermo Fisher Scientific, Vitagene, and MicroGenDx)
  • Nasal Swabs Maintain Market Dominance
    • Table 3-3 Selected COVID-19 Self-Tests Using A Nasal Swab (Abbott Labs, Becton Dickinson & Co [BD], Cue Health, Ellume, Eurofins Clinical Enterprise, Fulgent Genetics, Iowa State University, Laipac Technology, Lucira Health, Quidel Corp., Siemens Healthineers)
  • Saliva Sampling Gains Popularity
    • Table 3-4 Selected Saliva-Based Self-Tests for COVID-19 (Clinical Reference Laboratory, Fluidigm, Hoth Therapeutics, Medusa 19, Nuclein, OraSure Technologies, Vault Health, and Vitagene)
  • Alternative Sampling Innovations
    • Table 3-5 Selected COVID-19 Tests Using Alternate Samples (Breathonix, Canary Health Technologies, Gadjah Mada University, GreyScan, Next-Gen, Northumbria University, Ohio State University, Scentech Medical, and PerkinElmer)

 

Chapter 4: COVID-19 Home Test Modalities

  • Background
    • Table 4-1 Major Test Technologies Used in Rapid Diagnostic Tests for COVID-19 (PCR, EIA, LF EIA, CRISPR, Biosensor, LAMP)
  • Traditional Molecular – PCR, LAMP
    • Table 4-2Selected Home and POC Molecular COVID-19 Tests (Abbott Labs, BioFire Diagnostics/biomérieux,Cepheid, Clinical Reference Laboratory, Cue Health, Fluidigm, Fulgent Genetics, GenMark/Roche Diagnostics, HiberGene Diagnostics, Lucira Health, Mesa Biotech, OralDNA Labs, Vault Health, and Vitagene)
  • CRISPR & Biosensors
    • Table 4-3 Selected CRISPR and Biosensor–Based Devices for COVID-19 Testing (Arizona State University, Bilkent University, Blink Science, GLC Medical, Hoth Therapeutics, Identify Sensors Biologics, Iowa State University, Pennsylvania State University, Broad Institute of MIT, CSIR-Institute of Genomics, Gladstone Institutes, Mammoth Biosciences, and Sherlock Biosciences)
  • COVID-19 Antigen Testing By Immunoassay
    • Table 4-4 Selected FDA EUA and CE Marked COVID-19 Antigen Immunoassays (Abbott Labs, AccessBio, Becton Dickinson & Co [BD] Ellume, Laipac Technology, Mast Group, Medusa 19, Mologic, PerkinElmer, Quidel Corp., Roche Diagnostics, SD Biosensor, and Siemens Healthineers)
  • COVID-19 Antibody Tests by Immunoassay
    • Table 4-5 Selected FDA EUA and CE Marked COVID-19 Antibody Immunoassays (Assure Tech, bioLytical Laboratories, bio Mérieux, Cellex, Eurofins Technologies, Healgen Scientific, NovaBay Pharmaceuticals, NOWDiagnostics, PerkinElmer, Quest Diagnostics, SD Biosensor, Vatic, and Verify Diagnostics)

 

Chapter 5: Rapid COVID-19 Tests Migrate to OTC and DTC Venues

  • Background
  • OTC and DTC Initiatives
    • Table 5-1 Selected OTC and DTC COVID-19 Test Initiatives (Abbott Labs, Becton Dickinson & Co [BD], Clinical Reference Laboratory, Cue Health, Ellume, Laboratory Corp. America [LabCorp], Laipac Technology, Lucira Health, Quest Diagnostics, and Quidel Corp.)
  • And Now For Something A Little Bit Different
    • Table 5-2 Selected Novel COVID-19 Test Initiatives (3M, Fitbit, Identify Sensors Biologics, Johns Hopkins University, NeuTigers, Northwestern University, and Pennsylvania State University)

 

Chapter 6: COVID-19 Self and Home Testing in the Post Pandemic Era

  • Background
  • What Is The Status Quo
  • The Future For Home Covid-19 Tests

 

Chapter 7: Company Summaries

  • Background
  • Abbott Laboratories
  • Becton Dickinson & Company (BD)
  • Biomérieux / Biofire Diagnostics
  • Cepheid, a Danaher Company
  • Fluidigm Corporation
  • Genmark Diagnostics, Inc.
  • LetsGetChecked/PrivaPath Diagnostics Limited
  • Lucira Health
  • Mesa Biotech
  • Orasure Technologies, Inc.
  • QIAGEN N.V.
  • Quidel Corporation
  • Roche Diagnostics
  • Sherlock Biosciences

Our Knowledge Center provides access to

all market reports